Email
Print
Syringes Market Overview
Syringes Market Size is estimated to reach $17.1 billion by
2027. Furthermore, it is poised to grow at a CAGR of 9.8% over the forecast
period of 2022-2027. A syringe is a simple reciprocating pump with a plunger
that fits securely within a barrel, which is a cylindrical tube. The syringe
may take in and expel liquid or gas through a discharge aperture at the front
end of the tube by linearly pulling and pushing the plunger along the inside of
the tube. Generally, these are used to inject or withdraw fluids from the body
using a needle, especially a hypodermic needle. Nowadays, plastic syringes are
widely used as they are disposable after initial use which ensures safe use of
the same.
Mostly, in chronic and Infectious diseases syringes are used
since intravenous therapy in fatal and resistant Infectious diseases and subcutaneous
Insulin in type-1 diabetes are required treatments. Generally, syringes need a
lubricant but the BD Luer-Lok syringe is lubricant-free to prevent side effects
owing to lubricant. Currently, Intravenous and subcutaneous Insulins are
available in the market for type-1 diabetes patients. The COVID-19 pandemic led
to enhance the use of syringes for vaccines and other diseases such as thromboembolism
owing to clots induced by COVID-19. In addition, Intravenous antimicrobials are
preferred in severe infections induced by COVID -19. Thus, COVID 19 and Chronic
diseases are driving the Syringes Industry.
Syringes Market Report Coverage
The report: “Syringes Market Forecast (2022-2027)", by
Industry ARC covers an in-depth analysis of the following segments of the
Syringes Market.
By Product type – General syringes, Specialised
syringes, and Smart syringes.
By Usage – Disposable syringes and Reusable syringes.
By Material – Glass, Plastic syringes.
By Distribution channel – Online and offline.
By End Users – Hospitals, Ambulatory Centres,
Clinics, Community Healthcare, and Others.
By Geography – North America (U.S., Canada, Mexico),
Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and the Rest
of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New
Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest
of South America), and Rest of the World (the Middle East, and Africa).
Key takeaways
- Geographically, North America held a dominant market share in the year 2021 on account of the increasing prevalence of chronic diseases. Asia-Pacific is estimated to offer lucrative growth opportunities to the manufacturers owing to the increasing prevalence of Chronic diseases., demand for better healthcare facilities as well a boost in the investments done by government and private companies in the pharma industry. The proliferation of Chronic diseases especially type-1 diabetes is predicted to augment the market growth during the forecast period of 2022-2027.
- Chronic diseases are estimated to drive the market growth of the Syringes Market.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Syringes Market Report.
Syringes Market: Market Share (%) by region, 2021
For more details on this report - Request for Sample
Syringes Market Segmentation Analysis - By Usage
Syringes Market based on drug type can be further segmented
into disposable and reusable. Disposables held a dominant market share in the
year 2021 primarily owing to safety and are estimated to be the fastest-growing,
with a CAGR of 10.4% over the forecast period of 2022-2027. Disposable syringes
are sterile and used only one time which ensures the safety and moreover prevents
fatal infections. According to World Health Organisation (WHO), in the year
2016, Infectious diseases can be prevented by using disposable syringes are the
major reason for the increasing market for disposable syringes. Nevertheless,
prefilled syringes are going to be popularised in the future as per WHO.
According to Occupational Safety and Health Administration
(OSHA) estimates, in the year 2000, every year around 384,000 health care
professionals suffer from needle stick injuries, thereby, enhancing the segment
expansion.
Syringes Market Segmentation Analysis - By Material
Syringes Market based on drug type can be further segmented
into Plastic and glass. Plastic held a dominant market share in the year 2021
primarily owing to reusable and is estimated to be the fastest-growing, with a
CAGR of 10.6% over the forecast period of 2022-2027. Plastic Injection-molded
syringes made from polypropylene resin. The plunger, main body, which is
graduated to show capacity, gasket, needle holder, and needle sheath cover are
among the components. According to NCBI,
in 2000, plastic syringes are used as a single shot during vaccination. Plastic
syringes are reusable and can be discarded after one shot. However, glass
syringes are sterile but they are fragile and expensive to manufacture, thus
generating Plastic syringes revenue.
Syringes Market Segmentation Analysis – By Geography
The Syringes Market based on Geography can be further segmented
into North America, Europe, Asia-Pacific, South America, and the Rest of the
World. North America held a dominant market share of 32% in the year 2021 as
compared to the other counterparts on account of well-developed healthcare
infrastructure, increasing prevalence of infectious diseases, and higher
purchasing power of the consumers. For instance, the Development Finance
Corporation had approved a $590 million loan to support construction that can
produce up to 3 billion single-dose prefilled plastic injectors.
However, Asia Pacific is estimated to be the fastest-growing, over the forecast period of 2022-2027 owing to the pandemic and
increasing use of syringes in hospitals owing to the high number of
hospitalizations and vaccinations. These hospitalizations are followed
by a series of tests involving blood samples and the injection of various
medications to manage the virus's symptoms which are projected to enhance even
more.
Furthermore, Syringes Market is estimated to be growing in the Asia Pacific region as participants are always focused on product introductions, which is propelling the region's market expansion. For example, Sunshine Guojian Pharmaceutical, a subsidiary of 3SBio, reported in August 2019 that Yisaipu, a biosimilar of Enbrel (etanercept), had been approved in China as a pre-filled syringe to treat ankylosing spondylitis.
Syringes Market Drivers
Prevalence of chronic diseases like Type-1 Diabetes, Hypertension is driving the Market for Syringes
The enhancement in the prevalence of chronic diseases like type-1 diabetes which is also called Insulin Dependent Diabetes Mellitus (IDDM). According to International Diabetes Federation, In 2021, approximately 537 million adults (20-79 years) are living with diabetes and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. 3 in 4 adults with diabetes live in low- and middle-income countries and almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. Further, Diabetes caused 6.7 million deaths in 2021. Currently, Insulin is the option available for IDDM treatment. As Insulin is a hormone as its large size and sensitivity to gastrointestinal enzymes cannot be absorbed orally. Thus, it needs to be administered subcutaneously and rarely intravenously by using a specialized syringe named Insulin syringe. Additionally, in emergency and resistant cases; Insulin is the only option available even for type-2 diabetes patients. Hence, Chronic diseases are the key factor driving the growth of the Syringes Market.
Usage of syringes in COVID-19 and other infectious disease like Hepatitis B vaccination is driving the Syringes Market
Vaccines are biological preparations that can prevent
infectious diseases by developing immunity against fatal and untreatable
infections, especially in children. According to United Nations International
Children's Emergency Fund (UNICEF), Measles vaccines alone are
estimated to have prevented around 21 million deaths between 2000-2017. The
maximum number of vaccines are administered through syringes. Vaccines are
majorly administered to children to immunize to prevent fatal and untreatable
infections. UNICEF is the largest member to purchase auto disposable syringes;
40% of the global market. Thus, vaccines are one of the supreme factors driving
the market for syringes.
Syringes Market Challenges
Needlestick injuries of syringes poses threat to market growth.
Needlestick injuries are a major challenge for syringes; can
cause infections primarily including HIV, HBV, and HCV. According to the Centers
for Disease Control and Prevention (CDC) in 2018, an estimated 600,000 to 800,000
needle stick injuries occurred. Nurses and other healthcare professionals face
a severe risk of needlestick injuries. One of the most serious clinical
consequences of needlestick injuries is the danger of contracting blood-borne
illnesses like hepatitis and HIV. To reduce the danger and impact of
needlestick injuries, a variety of interventions have been implemented,
including the use of fixed-needle safety syringes. Some healthcare providers,
on the other hand, reject the utilization of such devices for a variety of reasons,
including the apparent requirement to replace syringe needles between preparing
medicine and administering it to a patient. Hence, Needlestick injuries are one
of the challenges for Syringes Market.
Syringes Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and
geographical expansions are key strategies adopted by players in the Syringes
Market. The top syringes Market companies are-
- Becton Dickinson
- Braun Melsungen
- Terumo
- Teleflex
- Nipro
- Smith’s Medical
- Cardinal Health
- Phenomenex, Inc
- Hutchins & Hutchins
- Qosina corp.
Recent Developments
- In October 2019, Becton Dickinson, launched BD Intevi 1mL two-step disposable autoinjector, a device that combines an autoinjector and a pre-fillable syringe in one integrated system, which has been released by BD. The BD autoinjector is a new generation of BD autoinjectors that will allow medication producers to improve drug administration in a seamless manner. The platform technology is meant to make self-injecting easier for patients.
- In September 2019, Braun Melsungen in collaboration with Royal Philips launched vision needle tip tracking to ensure accurate positioning of the needle in the body. It helps anesthesiologists to perform anesthesia procedures in a safe and effective manner by avoiding complications such as peripheral nerve blocks.
- In December 2020, Smiths Medical launched the Echoglo needle for peripheral nerve block has been launched. With a combination of clockwise and counter-clockwise grooves, the grooves are designed to reflect acoustic energy back to the transducer, making echogenic visibility possible.